Back
Santander Bank Polska SA Vs. Xenon Pharmaceuticals, Inc. Industry Stock Comparison
Buy
65
BKZHF
Santander Bank Polska SA
Last Price:
$166.92
Seasonality Move:
0%
Buy
62
XENE
Xenon Pharmaceuticals, Inc.
Last Price:
$56.89
Seasonality Move:
4.19%
Buy
65
Santander Bank Polska SA (BKZHF)
is a Buy
Is Santander Bank Polska SA a Buy, Sell or Hold?
-
The current Santander Bank Polska SA [BKZHF] share price is $166.92. The Score for BKZHF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
BKZHF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Xenon Pharmaceuticals, Inc. (XENE)
is a Buy
Is Xenon Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Xenon Pharmaceuticals, Inc. [XENE] share price is $56.85. The Score for XENE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
XENE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BKZHF Stock Price Chart
What is Santander Bank Polska SA's stock price today?
-
The Santander Bank Polska SA share price today is $166.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKZHF is experiencing slight buying pressure.
XENE Stock Price Chart
What is Xenon Pharmaceuticals, Inc.'s stock price today?
-
The Xenon Pharmaceuticals, Inc. share price today is $56.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XENE is experiencing slight buying pressure.
BKZHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 37.2 | Buy |
| Relative Strength Index (14 RSI): | 94.52 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (166.92 - 166.92) | Buy |
| Bollinger Bands (100): | (45.25 - 161.23) | Buy |
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 61.55 | Buy |
| Chaikin Money Flow: | 226752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.95 - 59.27) | Buy |
| Bollinger Bands (100): | (39.35 - 50.85) | Buy |
BKZHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.92 | Sell |
| 20-day SMA: | 166.92 | Sell |
| 50-day SMA: | 161 | Buy |
| 200-day SMA: | 74.36 | Buy |
| 8-day EMA: | 163.93 | Buy |
| 20-day EMA: | 133.27 | Buy |
| 50-day EMA: | 78.91 | Buy |
| 200-day EMA: | 24.68 | Buy |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.78 | Buy |
| 20-day SMA: | 55.66 | Buy |
| 50-day SMA: | 47.7 | Buy |
| 200-day SMA: | 40.77 | Buy |
| 8-day EMA: | 56.09 | Buy |
| 20-day EMA: | 54.07 | Buy |
| 50-day EMA: | 49.75 | Buy |
| 200-day EMA: | 42.9 | Buy |
Santander Bank Polska SA Earnings Growth & BKZHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xenon Pharmaceuticals, Inc. Earnings Growth & XENE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.55 per share, and an increase next year of $0.10 per share.
Santander Bank Polska SA Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xenon Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||